Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MannKind: Why The Short Argument Is Shortsighted
Seeking Alpha
Saturday, July 26, 2014 - 9:54am
tags:
MannKind, Afrezza
MannKind Pharma Gets Hedge Fund Treatment, Traders Rally Defence
Yahoo/StockTwits
Saturday, July 26, 2014 - 9:53am
tags:
MannKind, Afrezza
Inovio Data Not A Home Run, But Got Company In Great Scoring Position
Seeking Alpha
Saturday, July 26, 2014 - 9:51am
tags:
Inovio, VGX-3100, cervical dysplasia
MannKind Afrezza Partnership News Coming Within Weeks
The Street
Saturday, July 26, 2014 - 9:50am
tags:
Afrezza, MannKind, diabetes, inhaled insulin
As legislator rails on potential Valeant-Allergan deal, Wall Street lines up to fund it
Fierce Pharma
Friday, July 25, 2014 - 6:00pm
tags:
Valeant Pharmaceuticals, Allergan, M&A
J&J builds 9-month supply of Doxil with creative problem solving
Fierce Pharma
Friday, July 25, 2014 - 5:59pm
tags:
JNJ, Boehringer Ingelheim, Doxil, drug shortage, Janssen, ovarian cancer
Long-Shot Breast Cancer Drug Now Promises Fortune, but Not for Big Pharma
Yahoo/Bloomberg
Friday, July 25, 2014 - 5:57pm
tags:
breast cancer, Pfizer, neratinib, Puma Biotechnology
Arena Sees Belviq Sales Climb Despite Seasonality
Seeking Alpha
Friday, July 25, 2014 - 5:55pm
tags:
Belviq, obesity, Arena Pharmaceuticals
Why Bristol-Myers Squibb Loses Out Against This Rival
Seeking Alpha
Friday, July 25, 2014 - 5:54pm
tags:
Express Scripts, Bristol-Myers Squibb
Merck Cuts 600 Sales Reps as Part of its Ongoing Reorganization
WSJ Online
Friday, July 25, 2014 - 5:53pm
tags:
Merck, layoffs, reorganization
Keryx touts its kidney drug with an FDA decision around the corner
Fierce Biotech
Friday, July 25, 2014 - 11:14am
tags:
Keryx, FDA, hyperphosphatemia, kidney dialysis, Zerenex
Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
RTT News
Friday, July 25, 2014 - 11:11am
tags:
Bayer, ONYX Pharmaceuticals, Nexavar, breast cancer
AstraZeneca results to get lift from bid foe Pfizer
Yahoo/Reuters
Friday, July 25, 2014 - 11:08am
tags:
Pfizer, M&A, earnings, AstraZeneca
Glaxo Investigates Allegations of Bribery in Syria
Bloomberg
Friday, July 25, 2014 - 11:06am
tags:
GSK, Syria, bribery
IPO Preview: Ocular Therapeutix
Seeking Alpha
Friday, July 25, 2014 - 11:01am
tags:
IPOs, Ocular Therapeutix
IPO Preview: Innocoll GmbH
Seeking Alpha
Friday, July 25, 2014 - 11:01am
tags:
Innocoll GmbH, IPOs
Roche's breast cancer franchise keeps delivering, with huge jumps for Perjeta, Kadcyla
Fierce Pharma
Friday, July 25, 2014 - 9:18am
tags:
Roche, breast cancer, Perjeta, Kadcyla, earnings
Can Gilead break into cancer? With Zydelig approval, it gets its chance
Fierce Pharma
Friday, July 25, 2014 - 9:16am
tags:
Gilead Sciences, Zydelig, PI3k inhibitor, Roche
Novo sees two-in-one diabetes drug in Europe in H1 2015
Reuters
Friday, July 25, 2014 - 9:14am
tags:
Novo Nordisk, diabetes, Europe, insulin
Acrux Limited soars on positive quarterly sales numbers: Is there time to buy?
Motley Fool
Friday, July 25, 2014 - 9:07am
tags:
Acrux, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.